These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14657424)

  • 21. Precipitating factors for pharmaceutical firms.
    McCarthy R
    State Health Care Am; 1997; ():39-43. PubMed ID: 10168083
    [No Abstract]   [Full Text] [Related]  

  • 22. Managing the drug benefit: one company's experience.
    Kaye T
    Manag Care; 2002 Jul; 11(7):34-8, 40. PubMed ID: 12219374
    [No Abstract]   [Full Text] [Related]  

  • 23. Is the market ready for direct pharmaceutical contracting by employers?
    Giaquinta D
    Manag Care Interface; 2004 Aug; 17(8):33-4. PubMed ID: 15471109
    [No Abstract]   [Full Text] [Related]  

  • 24. A first look at the new Medicare prescription drug plans.
    Frakt AB; Pizer SD
    Health Aff (Millwood); 2006; 25(4):W252-61. PubMed ID: 16720588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.
    Gudiksen KL; King JS
    J Leg Med; 2019; 39(2):95-120. PubMed ID: 31503534
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of a three-tier prescription copay on pharmaceutical and other medical utilization.
    Motheral B; Fairman KA
    Med Care; 2001 Dec; 39(12):1293-304. PubMed ID: 11717571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consumers face higher costs as health plans seek to control drug spending.
    Mays GP; Hurley RE; Grossman JM
    Issue Brief Cent Stud Health Syst Change; 2001 Nov; (45):1-4. PubMed ID: 11865903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Managing prescription drug costs: a case study.
    DuBois RW; Feinberg PE
    Med Interface; 1994 Jun; 7(6):65-8, 70, 74. PubMed ID: 10135321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unraveling the effects of tier-copayment drug benefit designs.
    Curtiss FR
    J Manag Care Pharm; 2003; 9(2):177-8. PubMed ID: 14613348
    [No Abstract]   [Full Text] [Related]  

  • 30. Prescription drug copayments--fiduciary duty--plan discounts--disclosure. Alves v. Harvard Pilgrim Health Care, Inc.
    Benefits Q; 2005; 21(2):61-3. PubMed ID: 15977753
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacy directors, employers paint picture of HMO pharmacy benefit.
    Am J Health Syst Pharm; 1996 Sep; 53(18):2136, 2142. PubMed ID: 8879318
    [No Abstract]   [Full Text] [Related]  

  • 32. Effective strategies for managing pharmacy benefits.
    Jacobson D
    Healthc Financ Manage; 2001 Mar; 55(3):41-2. PubMed ID: 11258270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilization effects of prescription drug benefits in an aging population.
    Gianfrancesco FD; Baines AP; Richards D
    Health Care Financ Rev; 1994; 15(3):113. PubMed ID: 10137793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Choices in prescription-drug benefit programs: mail versus community pharmacy services.
    Kirking DM; Ascione FJ; Richards JW
    Milbank Q; 1990; 68(1):29-51. PubMed ID: 2215427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developing an effective generic prescription drug program.
    Jones JD
    Benefits Q; 2003; 19(1):14-8. PubMed ID: 12608114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Data watch. How employers are tackling Rx costs.
    Bus Health; 1999 Jul; 17(7):48. PubMed ID: 10539172
    [No Abstract]   [Full Text] [Related]  

  • 37. New standard for pharmacy benefits.
    Walgran CC
    J Health Care Benefits; 1994; 3(3):60-4. PubMed ID: 10131221
    [No Abstract]   [Full Text] [Related]  

  • 38. Frequency and Magnitude of Co-payments Exceeding Prescription Drug Costs.
    Van Nuys K; Joyce G; Ribero R; Goldman DP
    JAMA; 2018 Mar; 319(10):1045-1047. PubMed ID: 29536088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlling spending for prescription drugs.
    Altman SH; Parks-Thomas C
    N Engl J Med; 2002 Mar; 346(11):855-6. PubMed ID: 11893800
    [No Abstract]   [Full Text] [Related]  

  • 40. Medicare prescription drug plan costs and affordability--2007.
    Davis MM
    J Gen Intern Med; 2007 Aug; 22(8):1221-2. PubMed ID: 17497191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.